Pegylated polyelectrolyte nanoparticles containing paclitaxel as a promising candidate for drug carriers for passive targeting

Colloids and Surfaces B: Biointerfaces

Volumn 143, Issue , 2016, Pages 463-471

  Szczepanowicz, Krzysztof ^a   Bzowska, Monika ^b   Kruk, Tomasz ^a   Karabasz, Alicja ^b   Bereta, Joanna ^b   Warszynski, Piotr ^a  

^a INSTITUTE OF CATALYSIS AND SURFACE CHEMISTRY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Drug delivery; Nanoparticles; Paclitaxel; Passive targeting; Polyelectrolytes

Indexed keywords

AMINO ACIDS; BIOCOMPATIBILITY; CELL CULTURE; CELLS; CYTOLOGY; DRUG DELIVERY; EMULSIFICATION; EMULSIONS; MAMMALS; NANOPARTICLES; POLYELECTROLYTES; TUMORS;

COLON CARCINOMA CELLS; MAMMARY CARCINOMA CELL; PACLITAXEL; PASSIVE TARGETING; POLY-L-GLUTAMIC ACIDS; POLYELECTROLYTE MULTILAYER; TARGETED DRUG DELIVERY; TARGETED DRUG DELIVERY SYSTEMS;

SYNTHESIS (CHEMICAL);

ANTINEOPLASTIC AGENT; BIOMATERIAL; DOCUSATE SODIUM; DRUG CARRIER; NANOCARRIER; NANOPARTICLE; PACLITAXEL; POLYELECTROLYTE; POLYGLUTAMIC ACID; POLYLYSINE; EMULSION; MACROGOL DERIVATIVE; POLY(ETHYLENE GLYCOL)-B-POLY(LEUCINE)-B-POLY(GLUTAMIC ACID) TRIBLOCK COPOLYMER;

ADSORPTION KINETICS; ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CARCINOMA; CELL VIABILITY; COLON CARCINOMA; CULTURE MEDIUM; CYTOSTASIS; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; MOUSE; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; SYNTHESIS; TUMOR CELL LINE; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; EMULSION; MOLECULARLY TARGETED THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; DIOCTYL SULFOSUCCINIC ACID; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; MICE; MOLECULAR TARGETED THERAPY; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYELECTROLYTES; POLYETHYLENE GLYCOLS; POLYGLUTAMIC ACID; POLYLYSINE;

EID: 84962261512     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.03.064     Document Type: Article

References (46)

1. Press release WHO/52-28 June 2002. World Health Organization Geneva.
2. Maeda K. The EPR Effect and Polymeric Drugs: A Paradigm Shift for Cancer Chemotherapy in the 21st Century 2006, 103-121. Springer, Berlin Heidelberg. R. Satchi-Fainaro, R. Duncan (Eds.).
3. Kim S.H., Jeong J.H., Chun K.W., Park T.G. Target-specific cellular uptake of PLGA nanoparticles coated with poly(l-lysine) poly(ethylene glycol) folate conjugate. Langmuir 2005, 21:8852-8857.
4. Dhar S., Gu F.X., Langer R., Farokhzad O.C., Lippard S.J. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc. Natl. Acad. Sci. 2008, 105:17356-17361.
5. Gao X., Chen J., Tao W., Zhu J., Zhang Q., Chen H., Jiang X. UEA I-bearing nanoparticles for brain delivery following intranasal administration. Int. J. Pharm. 2007, 340:207-215.
6. Fay F., Scott C.J. Antibody-targeted nanoparticles for cancer therapy. Immunotherapy 2011, 3:381-394.
7. Kim J., Kim J., Park J., Byun Y., Kim C. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator. Biomaterials 2009, 30:5751-5756.
8. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46:6387-6392.
9. Matsumura Y., Kataoka K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci. 2009, 100:572-579.
10. Sukhorukov G.B., Donath E., Lichtenfeld H., Knippel E., Knippel M., Budde A., Möhwald H. Layer-by-layer self assembly of polyelectrolytes on colloidal particles. Colloids Surf. Physicochem. Eng. Aspects 1998, 137:253-266.
11. Voigt A., Lichtenfeld H., Sukhorukov G.B., Zastrow H., Donath E., Bäumler H., Möhwald H. Membrane filtration for microencapsulation and microcapsules fabrication by layer-by-layer polyelectrolyte adsorption. Ind. Eng. Chem. Res. 1999, 38:4037-4043.
12. Borodina T.N., Rumsh L.D., Kunizhev S.M., Sukhorukov G.B., Vorozhtsov G.N., Feldman B.M., et al. Polyelectrolyte microcapsules as systems for delivery of biologically active substances. Biomed. Khim. 2007, 53:557-565.
13. Guzey D., McClements D.J. Formation, stability and properties of multilayer emulsions for application in the food industry. Adv. Colloid Interface Sci. 2006, 128-130:227-248.
14. Grigoriev D.O., Bukreeva T., Mohwald H., Shchukin D.G. New method for fabrication of loaded micro- and nanocontainers: emulsion encapsulation by polyelectrolyte layer-by-layer deposition on the liquid core. Langmuir 2008, 24:999-1004.
15. Szczepanowicz K., Bazylińska U., Pietkiewicz J., Szyk-Warszyńska L., Wilk K.A., Warszyński P. Biocompatible long-sustained release oil-core polyelectrolyte nanocarriers: from controlling physical state and stability to biological impact. Adv. Colloid Interface Sci. 2015, 222:678-691.
16. Szczepanowicz K., Podgórna K., Szyk-Warszynska L., Warszynski P. Formation of oil filled nanocapsules with silica shells modified by sequential adsorption of polyelectrolytes. Colloids Surf. Physicochem. Eng. Aspects 2014, 441:885-889.
17. Piotrowski M., Szczepanowicz K., Jantas D., Leśkiewicz M., Lasoń W., Warszyński P. Emulsion-core and polyelectrolyte-shell nanocapsules: biocompatibility and neuroprotection against SH-SY5Y cells. J. Nanopart. Res. 2013, 15:1-12.
18. Adamczak M., Krok M., Pamuła E., Posadowska U., Szczepanowicz K., Barbasz J., Warszyński P. Linseed oil based nanocapsules as delivery system for hydrophobic quantum dots. Colloids Surf. B 2013, 110:1-7.
19. Lukasiewicz S., Szczepanowicz K. In vitro interaction of polyelectrolyte nanocapsules with model cells. Langmuir 2014, 30:1100-1107.
20. Karabasz A., Bzowska M., Łukasiewicz S., Bereta J., Szczepanowicz K. Cytotoxic activity of paclitaxel incorporated into polyelectrolyte nanocapsules. J. Nanopart. Res. 2014, 16:1-14.
21. Adamczak M., Kupiec A., Jarek E., Szczepanowicz K., Warszynski P. Preparation of the squalene-based capsules by membrane emulsification method and polyelectrolyte multilayer adsorption. Colloids Surf. Physicochem. Eng. Aspects 2014, 462:147-152.
22. Bazylinska U., Skrzela R., Piotrowski M., Szczepanowicz K., Warszynski P., Wilk K.A. Influence of dicephalic ionic surfactant interactions with oppositely charged polyelectrolyte upon the in vitro dye release from oil core nanocapsules. Bioelectrochemistry 2012, 87:147-153.
23. Kingshott P., Griesser H.J. Surfaces that resist bioadhesion. Curr. Opin. Solid State Mater. Sci. 1999, 4:403-412.
24. Torchilin V.P., Trubetskoy V.S. Which polymers can make nanoparticulate drug carriers long-circulating?. Adv. Drug Deliv. Rev. 1995, 16:141-155.
25. Milton Harris J., Chess R.B. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2003, 2:214-221.
26. Vermette P., Meagher L. Interactions of phospholipid- and poly(ethylene glycol)-modified surfaces with biological systems: relation to physico-chemical properties and mechanisms. Colloids Surf. B 2003, 28:153-198.
27. Halperin A. Polymer brushes that resist adsorption of model proteins: design parameters. Langmuir 1999, 15:2525-2533.
28. Zhu B., Eurell T., Gunawan R., Leckband D. Chain-length dependence of the protein and cell resistance of oligo(ethylene glycol)-terminated self-assembled monolayers on gold. J. Biomed. Mater. Res. 2001, 56:406-416.
29. Parekh G., Pattekari P., Joshi C., Shutava T., DeCoster M., Levchenko T., Torchilin V., Lvov Y. Layer-by-layer nanoencapsulation of camptothecin with improved activity. Int. J. Pharm. 2014, 465:218-227.
30. Celis J. Cell Biology 1998, A Laboratory Handbook.
31. Matassov T., Kagan J., Leblanc M. Measurement of Apoptosis by DNA Fragmentation 2016, 1-17. Humana Press, 2004. H.M. Brady (Ed.).
32. Szczepanowicz K., Dronka-Góra D., Para G., Warszyński P. Encapsulation of liquid cores by layer-by-layer adsorption of polyelectrolytes. J. Microencapsul. 2010, 27:198-204.
33. http://www.fda.gov.
34. Szczepanowicz K., Hoel H.J., Szyk-Warszynska L., BielanÌska E., Bouzga A.M., Gaudernack G., Simon C., Warszynski P. Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorption. Langmuir 2010, 26:12592-12597.
35. Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv. Drug Deliv. Rev. 2011, 63:161-169.
36. Iversen T., Skotland T., Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 2011, 6:176-185.
37. Voinova M.V., Rodahl M., Jonson M., Kasemo B. Viscoelastic acoustic response of layered polymer films at fluid-solid interfaces: continuum mechanics approach. Phys. Scr. 1999, 59:391.
38. Lukasiewicz S., Szczepanowicz K. In vitro interaction of polyelectrolyte nanocapsules with model cells. Langmuir 2014, 30:1100-1107.
39. Chen J., Hessler J.A., Putchakayala K., Panama B.K., Khan D.P., Hong S., Mullen D.G., DiMaggio S.C., Som A., Tew G.N., Lopatin A.N., Baker J.R., Banaszak Holl M.M., Orr B.G. Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes. J. Phys. Chem. B 2009, 113(32):11179-11185.
40. Gatoo M.A., Naseem S., Arfat M.Y., Mahmood Dar A., Qasim K., Zubair S. Physicochemical properties of nanomaterials: implication in associated toxic manifestations. BioMed Res. Int. 2014, 2014:498420.
41. Shang L., Nienhaus K., Nienhaus G. Engineered nanoparticles interacting with cells: size matters. J. Nanobiotechnol. 2014, 12:5.
42. de Salamanca A.E., Diebold Y., Calonge M., GarciÌa-Vazquez C., Callejo S., Vila A., Alonso M.J. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and In vivo tolerance. Invest. Ophthalmol. Vis. Sci. 2006, 47:1416-1425.
43. Morille M., Montier T., Legras P., Carmoy N., Brodin P., Pitard B., Benoît J., Passirani C. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials 2010, 31:321-329.
44. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine 2011, 6:715-728.
45. Chen L., Mccrate J.M., Lee J.C.-M., Li H. The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells. Nanotechnology 2011, 22:105708.
46. Thorek D.L.J., Tsourkas A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 2008, 29:3583-3590.